As aforementioned, the extranuclear function of EZH2 in tumorigenesis has been gradually noticed and validated in solid tumors, less has been explored in HER2-positive BC concerning EZH2, especially in aggressiveness and drug-resistance. Here, ERBB2 is linked to breast cancer.